Global Panic Disorders Market: Overview
When a patient suffers from frequent sudden panic attacks then that patient is suffering from the panic disorder which is a type of anxiety disorder. The patient has the following symptoms when panic attacks occur such as intense fear, sweating, shortness of breath, palpitations, shaking, numbness, etc. The reason or the cause for the panic attack is anonymous.
Request Free Sample Report @ www.zionmarketresearch.com/sample/panic-disorders-market
The panic disorder market is globally segmented into its type, drug class, and regions. On the basis of type, the global market is segregated into agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), bipolar disorder, post-traumatic stress disorder (PTSD), specific phobias, generalized anxiety disorder (GAD), and major depressive disorder. Based on the drug class, the market is categorized into selective serotonin reuptake inhibitor (SSRI), benzodiazepines (BZD), and serotonin-norepinephrine reuptake inhibitor (SNRI). The selective serotonin reuptake inhibitor (SSRI) is further sub-segmented into paroxetine (Paxil, Pexeva), fluoxetine (Prozac), and sertraline (Zoloft).
The increasing awareness regarding the disorders, growing prevalence of the mental and anxiety disorders, and the availability of treatment options that are effective are some of the key factors that estimate to fuel the growth of the global panic disorders market. The increasing initiatives that are being taken by the leading players in order to create an understanding among the consumers will accelerate the growth of the market. In the recent years, several drugs are in different phases of clinical trials, which will be commercialized soon thus encouraging the growth of the market. On the other hand, in underdeveloped and developing economies there is a lack of awareness regarding the severity of these disorders if not treated is the major factor that is likely to restrict the overall growth of the market in the coming years.
Request Report TOC (Table of Contents) @ www.zionmarketresearch.com/toc/panic-disorders-market
North America predicts to lead the global panic disorders market and hold a huge share in the global market. The high growth in this region can be attributed to the factors such as the presence of a large number of players that are involved in this field and the increasing awareness among the consumers regarding the accessibility of the therapeutics that are effective for the panic disorders. Europe expects to remain in the second position. Asia Pacific projects witnessing robust growth in the coming years, owing to the unexploited lucrative opportunities for the key players. In addition, the expanding purchasing capacity of the consumers in the region expects to encourage the growth of the market. India and China anticipate contributing considerably towards the growth of the panic disorders market in Asia Pacific region.
Market Competitive Players
Some of the key market players that are involved in the panic disorders market include Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International, Inc., Pfizer, Inc., H. Lundbeck A/S, Actavis Plc., Sanofi, Eli Lilly and Company, Neurocrine Biosciences, Inc., Mylan, Inc., and AstraZeneca Plc.
Browse detail report @ www.zionmarketresearch.com/report/panic-disorders-market
Panic Disorders Market by Geographical Analysis: North America( U.S.), Europe( UK, France, Germany), Asia-Pacific (China, Japan, India), Latin America( Brazil), Middle East and Africa
Our value reports provide full, in-depth analysis of the parent market including most significant changes in market dynamics; the report also presents the detailed overview on segmentation of this market. We managed to present as many important information in essential form – thanks to our report You will learn more about former, on-going, and projected market analysis in terms of volume and value, assessment of niche industry developments and Market share analysis. We have not forgotten to present key strategies for major players, emerging segments and regional markets and last but not least, testimonials to companies in order to fortify their foothold in the market
Inquire more before buying this report @ www.zionmarketresearch.com/inquiry/panic-disorders-market
About Us: Zion Market Research is an obligate company. We create futuristically, cutting edge, informative reports ranging from industry reports, a company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal Industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Visit Our Blog: zionmarketresearch.wordpress.com/